ConductScience.org, home

Trial · NCT07393373

Open-Label, Long-Term, Extension Study of Infigratinib in Children With Hypochondroplasia

NCT07393373, Phase 2, Enrolling by invitation, QED Therapeutics, a BridgeBio company

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Open-Label, Long-Term, Extension Study of Infigratinib in Children With Hypochondroplasia. Trials, record NCT07393373. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07393373

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Open-Label, Long-Term, Extension Study of Infigratinib in Children With Hypochondroplasia
NCT number
NCT07393373
Status
Enrolling by invitation
Phases
Phase 2
Enrollment
135 participants, estimated
Lead sponsor
QED Therapeutics, a BridgeBio company
Conditions
Hypochondroplasia
Interventions
Infigratinib
First posted
2026-02-06
Last updated
2026-08-26

Source ClinicalTrials.gov

Registered outcomes19

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryIncidence of treatment emergent adverse events (TEAE) and serious TEAE10 years
PrimaryChanges over time in standing height Z-score in relation to HCH and non-HCH growth charts10 years
SecondaryChanges over time in AHV Z-score10 years
SecondaryChanges over time in body proportions10 years
SecondaryChanges over time in weight Z-score10 years
SecondaryChanges overtime in BMI10 years
SecondaryAge of puberty onset and time to Tanner stage ≥410 years
SecondaryChanges over time in body composition as assessed by DXA (dual x-ray absorptiometry) scans10 years
SecondaryChanges over time in bone morphology/density by x-ray and DXA10 years
SecondaryChange in psychomotor function assessed by age-appropriate computerized tests (Detection Test)10 years

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests1

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

TestNamed as
1-Back TaskSecondary outcome

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07393373

GET https://conductscience.org/api/trials/v1/NCT07393373/registered